The table below features the cord lining/tissue releases performed by Cordlife Group Limited and its subsidiaries. As a Group, Cordlife has made 19 cord lining/tissue releases, all of which have been used successfully in cellular therapy.
Cordlife is proud to help these families in using their cord blood/cord lining/ tissues units stored in various Cordlife facilities for successful stem cell transplantation.
Joyce's parents were over the moon when they welcomed their baby girl into the world. They watched her grow, smiling at each new milestone she reached. However, when Joyce was just seven months old, their world came crashing down when she was diagnosed with hypoxic-ischemic encephalopathy.
Joyce had heart surgery to treat an underlying heart problem when she was six months old. The surgery caused oxygen deprivation in her brain, resulting in its shrinkage by 3%. She was unresponsive to external stimuli and had limited consciousness. Her parents were heartbroken that she had to deal with such a condition at such a young age, but they never gave up hope, even when doctors and specialists told them that her condition was incurable.
They searched for possible cures online and stumbled upon research papers and clinical trials that showed how cord blood infusion could help. They remembered that they had stored Joyce's cord blood with Cordlife Hong Kong when she was born and immediately reached out to Cordlife.
After receiving the request from Joyce's parents, the team at Cordlife Hong Kong immediately got in touch with the medical team, which decided to perform the cord blood infusion at the Hong Kong Children's Hospital. The procedure went smoothly, and Joyce did not feel any pain or have any negative side effects. The doctors gave Joyce a good prognosis, and she started to show signs of improvement soon after the infusion.
Joyce's vision improved, and she could now follow the source of light. Even though she still requires tube feeding, her ability to swallow has improved, and she can now swallow her own saliva. She also has more varied and frequent hand and foot movements, and her mental state improved significantly. Thanks to Cordlife's Transplant Care, which is an insurance benefit in the cord blood banking service agreement, the insurance payout helped ease her parents' financial burden, allowing them to focus more on Joyce's recovery.
Joyce has since been discharged from the hospital, and her parents believe that if financial resources allow, all parents should store their baby's precious cord blood. Cord blood can potentially be used to treat more than 80 diseases, such as blood cancers, blood disorders, and genetic diseases. If a child's cord blood was saved, it could be used to treat him/her and his/her family in the event of a health crisis.
Jaisheel and Archana Chabra, a couple from Meerut, were living a happy life with their daughter like any other family. On the 29th of October, 2016, the family was blessed with a baby boy named Jayant Chabra. Jayant's cord blood was preserved with Cordlife at the moment of delivery. And everything went according to plan. With God’s grace, their family picture has been completed with the arrival of their younger son. The child appeared to be completely normal.
However, the problem began four months after Jayant's birth, when the parents observed that their son was having some challenges that appeared to be significant, and they immediately sought medical advice. The doctor suggested certain tests, and when the results came out, he advised them to get some more blood tests done. The family's entire world was turned upside down when the blood test reports arrived.
The reports suggested that Jayant was suffering from Thalassaemia Major which is a genetic disorderthat occurs due to thedestruction of the red cells of the blood.
The couple had heard of the disorder but had no clue that how come this disorder being detected in their kid and how do they deal with it now. Further tests had been done as per the recommendation of their doctor and the results confirmed that the baby was suffering from Major Thalassaemia at the age of 5 months.
Because they had previously saved their Baby's cord blood unit with Cordlife, they were on their way to find a means to find a cure to the disorder the child was experiencing.During pregnancy with Jayant, his parents contacted Cordlife and had a brief discussion for 4-5 months about the services and benefits of Cord Blood banking and how it could be a life saver in the future if the need arose. They went on to preserve his cord blood with Cordlife.When the child was diagnosed with Thalassaemia, it was time for his parents to return to Cordlife, where his Cord Blood stem cells were stored.The father wrote to Cordlife to explain the dilemma they are in and to seek a solution. Cordlife assured him that they are there for the family and will assist them in any manner possible in accordance with the agreement for the child's treatment. In case of requirement Cordlife will procure the stem cells too by using its best endeavours from the public the bank in case the need arises for the transplantation.
At the time of transplantation Cordlife had sourced the matched stem cell unit for the kid from public repository. The cost of the treatment was very high till 40-45 lakhs. In which Cordlife helped them with that too. Cordlife had provided the client with the financial assistance from the insurance provider as promised.
The transplantation has been successful and the child recovering well.. After 5 years they were relieved and now their kid is living a healthy life.
Cordlife not only promised, but actually followed through on the words it did include in the agreement.As the mother of the kid rightly said - no one has seen the future. But in case the future puts your family in such a challenging situation, you need to have a weapon to deal with it and save your families future. This is an eye opener for all expectant parent and will help them to make the right decision of preserving their baby’s cord blood at the time of birth with Cordlife. So that in near future, god forbids, if any family face such adverse situation, Cordlife will support and help the family using the best possible endeavours as promised.
Eugene (not his real name) was diagnosed with leukaemia and doctors had given him only 10 per cent chance of recovery, unless he undergoes a bone marrow transplant. However, neither of his parents are a match and as an only child, he had a one in 20,000 chance of finding a non-related donor.
“We came across articles on how cord blood stem cells had been used to treat various blood-related disorders, including leukaemia,” said Eugene’s parents. “Cord blood stem cells also had a higher chance of successful matching as compared to bone marrow. We decided to conceive a second child and use the cord blood to save our son.”
In mid-2002, Eugene’s mother was found to be pregnant with a second child and they decided to store their baby’s precious cord blood with Cordlife. The baby’s cord blood was found to be a 100 per cent match for Eugene, which meant that not only could the cord blood be used, the transplant would also have a higher chance of success. The healthy cells from his sibling repopulated in his bone marrow and revived his immune system, that was previously depleted by the chemotherapy and radiotherapy used to treat the leukaemia.
“Eugene is doing very well now at home. He just started school and is enjoying every minute of it. We still need to be careful and make sure he does not tire himself out, but this is nothing compared to those dark days when he was really sick. The decision to collect his sister’s cord blood was the right one.” said Eugene’s mother.
“We refused to give up,” said Mr. Hasan and Mrs. Dwi Aprilia as they recalled the time when they found out that their daughter Harumi has cerebral palsy. This proclamation was the source of strength that kept this couple fighting on to nurse their baby back to health.
Nothing unusual happened during Harumi’s birth. Everything seemed fine. Yet, at only a few days old, the little baby experienced her first seizure. The first month of Harumi’s life was the hardest because her parents could not figure out what was happening to their baby daughter. She was only finally diagnosed with cerebral palsy after the family consulted several doctors. Harumi's parents had few options then. Someone told them to accept the reality but they insisted on not giving up and continued to tirelessly search for possible solutions to help their daughter.
When Harumi was born, her parents donated her umbilical cord to a laboratory owned by a friend. Under the advice of this friend, Harumi underwent her first stem cell therapy with stem cells obtained from her own umbilical cord. She was almost three months old at the time. After the therapy, Harumi's condition improved and she had lesser seizure episodes, which stopped eventually.
As Harumi's umbilical cord was not stored under optimal conditions, she only had enough stem cells for one infusion. While Mr. Hasan and Mrs. Dwi continued to search for other viable options, they put Harumi on regular physiotherapy to help develop her sensory and motor functions.
Five months later, a blessing came knocking on the family's door when Mrs. Dwi became pregnant with their second child. Encouraged by the positive result from using Harumi's umbilical cord stem cells, the couple decided to store their second child’s umbilical cord blood and umbilical cord lining as well. This time around, they selected a more well-established stem cell bank - Cordlife - to safeguard their baby son's precious biological resources.
A few months after Harumi turned two, she went through another stem cell therapy using her baby brother’s umbilical cord stem cells, collected and cryopreserved by Cordlife. This time, her parents noticed that Harumi's eyes can properly align with each other and she can visually follow light movements with ease.
The couple's undying perseverance in seeking help for their beloved daughter proved to be fruitful. Although Harumi still requires more interventions, the progress in her health and development gave hope to her parents.
For Mr. Hasan and Mrs. Dwi, Harumi’s unexpected predicament is a constant reminder not take things for granted and to do whatever they can within their means to safeguard their children's health. They also encourage parents of children with cerebral palsy not to give up. “No matter how big or small the chance is, every effort has its own fruit. And maybe, among the efforts, a miracle is waiting to be found,” said the couple.
Ching (alias) was diagnosed with Thalassemia Major. As a result, blood transfusion became part of her life. In attempt to free Ching of her suffering, her mother decided to meet Cordlife’s consultants to learn how cord blood can help Ching’s life. Luckily, doctors successfully performed a cord blood transplant when Ching was 5 years old at Hong Kong Queen Mary Hospital. Recovering swiftly, Ching is just like any other ordinary girls that enjoys school life.
When little Ee Han was 3 months old, his parents noticed that his neck was soft and could not hold his own head. He was then diagnosed with growth development delay and quadriplegic cerebral palsy. His ENT doctor also confirmed that he was suffering from severe hearing loss in both ears.
Since then, little Ee Han has been undergoing multiple therapies and depending on mobility and hearing aids to improve the quality of his life. At an Early Intervention Programme for Infants & Children (EIPIC) class outing, Ee Han’s parents chanced upon another child suffering from a similar condition who had improved tremendously after an infusion of his own cord blood. This encouraged them to let little Ee Han go through a cord blood infusion since they had stored his cord blood with Cordlife at birth.
In November 2014 and September 2015, Ee Han went through two rounds of cord blood infusion performed by Dr Keith Goh, Consultant Neurosurgeon from Mount Elizabeth Hospital. Each round took no more than 45 minutes to complete. After the infusions, both Dr Goh and Ee Han’s parents noted visible improvements including faster sitting up movements and better control of his emotions.
I noticed that Ee Han’s motor skills has improved and he now has more strength and control of his limbs. He can even walk with support. Ee Han is now more responsive and cognitively aware of things.
said Dr Keith Goh.
At the age of 2, Kamsiyochukwu was diagnosed with Sickle Cell Anaemia, a dreadful inherited blood disorder which affects the haemoglobin. Subject to multiple transfusions as part of the conventional treatment led to several complications which further deteriorated his health. Seeing their child’s critical condition, his parents were searching for a permanent cure to this pain and suffering. When they learnt that Cord Blood transfusion could help their child to get rid of this suffering, they planned for another baby in India and on the suggestion of their doctor, stored their 2nd child’s cord blood.
On 21st January, 2020, 8yr old Kamsiyochukwu underwent the transplantation at Apollo Hospital, India with his sibling’s Cord Blood Stem Cells. Before the transplantation, he underwent Chemotherapy to prepare his body for the cord blood transfusion. There were no adverse effects observed throughout the process and the transplant was declared successful. And since the transplant, Kamsiyochukwu has been okay and is leading painless life, back at their native - Nigeria.
Kamsiyochukwu’s mother, Blessing Ezenwa applauded Cordlife for not only safekeeping and timely delivery of the Cord Blood sample to the transplant centre at the time of need, but also for the financial insurance provided by Cordlife at the time of transplant. Ever since the transplant, little Kamsiyochukwu has been thankful to Cordlife for the new lease of life he received from his sibling’s cord blood.
Moinam was diagnosed Thalassamia when he was barely one year old. If left untreated, most of the children inflicted with this disorder do not live beyond the age of 10. Fortuitously, his newborn sister was free from Thalassamia and her cord blood stem cells were a perfect match for Moinam, with small amount of bone marrow to supplement the transplant, Moinam is now in his recovery phase and the results from his blood very heartening.
"We decided to use a mixture of bone marrow and cord blood cells as it has a better and faster chance of success than only bone marrow cells. Bone marrow stem cells, on the other hand, could lead to Graft Versus Host Disease, triggered by the body's defense mechanism while the transfusion is being done. Not only increase the stem cell count, but also reduce the chance of any complications. It is the treatment of choice in such cases and leads to a complete cure," explained Dr Mukherjee, Medical Director of NetajiSubhash Chandra Bose Cancer Research Institute.
Source: The Telegraph, 7 May 2011
Justin (alias) was diagnosed with a common childhood cancer, neuroblastoma, at a tender age of one and half years old. Over the course of 1 year, the child had to endure numerous rounds of high-dose chemotherapy to treat his condition. Chemotherapy destroyed cancer cells, but at the same time also killed normal cells. Fortunately, Justin’s parents had his cord blood stored at birth with CordLife. The cord blood stem cells were infused back to his body after a course of chemotherapy in January 2011 at Queen Mary Hospital and he was discharged from hospital after 3 months. The cord blood unit used had been cryopreserved in our Hong Kong facility for 29 months. CordLife is very proud to achieve this milestone in the cord blood banking industry in Hong Kong.
An accident at birth 2.5 years ago deprived Baby Georgia of oxygen to her brain, resulted in cerebral palsy. The damage to the toddler's brain caused her to move involuntarily, suffer from muscle spasms and have up to 50 seizures a day. It was only after CordLife put the family in touch with a renowned neurosurgeon that enable Georgia to be infused with her own cord blood, also stored by CordLife. Her conditions have improved since then.
"Georgia has made good progress since her stem cell infusion. She has better visual focus and eye contact with adults during play. She has more vocalization and tries to 'sing-a-song' by making different sounds to nursery rhymes. Georgia has improved postural and head control and is observed to be reaching more with her arms," said Ms. Jaclyn Tan, Consultant Occupational Therapist at OzWorks Therapy.
Source: The Sun, 3 December 2009
Lucas (alias), a young boy was active and normal until he turned 10 years old and he was constantly lethargic and had a poor appetite for no reason. He also had significant weight loss with bouts of fever and vomiting and had to go through months of seeking treatments in numerous hospitals in Malaysia. In 2017, he was finally diagnosed by doctors that he had chronic myeloid leukaemia. Thankfully, Lucas’s parents managed to find a match in his younger brother’s cord blood, which they had stored at birth with Stemlife (A subsidiary of Cordlife Group Limited). The transplant took place successfully in 2018 and he is in remission currently.
When Jason was five years old, his mother noticed that he was having trouble walking, and a subsequent examination revealed that he had neuroblastoma. Neuroblastoma is a form of childhood cancer that affects the nervous system of infants and children younger than five years old. During the initial stages of treatment, doctors at Queen Mary Hospital removed a portion of Jason's adrenal tissue and then administered a series of radiation and drug treatments.
When Jason's doctors learned that his parents had stored his cord blood with HealthBaby Hong Kong at the time of his birth, they recommended that he undergo a stem cell transplant using his own cord blood to repair damaged cells and restore haematopoietic and immune functions. The doctors evaluated and confirmed that Jason's cord blood unit is of adequate quality and quantity, and they believe that using cord blood in the transplant will yield better results than using bone marrow. Thankfully, the stem cell transplant was a success, which improved Jason's overall treatment success and long-term survival. After a year of observation following the transplant, doctors confirmed that Jason no longer had cancer cells in his body.
Not expecting it to be used in such a life-threatening situation, Jason's mother felt relieved to have made the right decision to store his cord blood. She and her husband hope that by speaking out, more expectant parents will become aware of the lifesaving benefits of cord blood, which can potentially be used to treat over 80 diseases, including certain cancers, blood disorders, and genetic disorders.
Stem cell isolation is a critical step in cord blood banking. It affects the number of stem cells that can be harvested or recovered from the cord blood. Cell recovery rates are critical because a higher number of stem cells could enhance the success of the transplant or treatment. That's why Cordlife has invested in the Sepax®2 automated stem cell processing technology, a safe, sterile and fully automated cord blood processing technology - so you get more stem cells for maximum transplant success*.
The first private cord blood bank in Singapore that offers the Sepax®2 automated processing technology, this Swiss-made and U.S. FDA-cleared device can recover as high as 99.88%1 of Total Nucleated Cells (TNC) from cord blood. It is also a functionally closed processing system which ensures the sterility of the cord blood by eliminating exposure to air contaminants.
*Kindly note that the above mentioned is general information only. Please refer to the Cordlife Service Agreement for full details and its terms and conditions. Cordlife Group Limited reserves the rights to amend or cancel any of the benefits listed above without prior notice. International quality standards may differ between the time of enrolment and time of release of your baby's cord blood unit for transplant. All reasonable efforts will be made to adhere to the prevailing standards at the time of release of your baby's cord blood unit. HLA testing and CFU Assay may or may not cease to become a mandatory quality check.Cordlife has taken added insurance coverage, to safeguard you and your family from financial loss that results from direct malpractice*.
Maximizing the recovery of Total Nucleated Cells (TNC) from your child's precious cord blood is one part of the equation. The next crucial step is ensuring that the cells are carefully prepared for cryopreservation so that they can be stored indefinitely while retaining its viability for treatment purposes.
Cordlife is the first family cord blood bank in Singapore to adopt the Smart-Max™ technology - a fully automated cryoprotectant infuser, mixer and cooling device that allows for the consistent preparation of stem cells for cryopreservation. Unlike other devices that require manual handling, this Swiss-made device has high precision and is the epitome of reliability and quality.
The razor sharp precision of Smart-Max™ injects cryoprotectant at a constant and pre-defined temperature without any deviation in protocol. This mixes the cryoprotectant homogeneously with the stem cells without the need for human interference, thus averting any chance of human error. This ensures that the quality of the stem cells is maintained as they are placed into the liquid nitrogen storage systems at below -150°C.
With this implementation of Smart-Max™ , Cordlife's cord blood processing is now fully automated from receipt to storage, therefore ensuring that your child's cord blood is well protected.
Runner-Up In The Mid And Small Category Of The 16th SIAS Investors’ Choice Awards 2015
Cordlife Honoured As One Of Forbes Asia’ s 2015 “Best Under a Billion” Companies
2015 Frost & Sullivan Singapore Stem Cell Banking Company of the Year Award
Baby Kingdom Top 10 Family Brand Award, 2015
Capital Weekly The Best Performance Company Awards 2013
Hong Kong Economic Times 2013 BABY & KID BRANDS AWARD
Securities Investors Association (Singapore) 14th SIAS Investors’ Choice Awards2013 Most Transparent Company Award
The Hong Kong Council of Social Service Caring Company 2011/12
Baby-Kingdom Top 10 Family Brand Award 2013
Baby-Kingdom Top 10 Family Brand Award 2012
GS1 Hong Kong Consumer Caring 2011
Baby-Kingdom Top 10 Family Brand Award 2011
Pregnancy Magazine Top Pregnant, Baby Products Awards 2010 - 2013
Capital CEO Supreme Brand Awards 2010 Best Medical Service Award
Quamnet Outstanding Enterprise Awards Outstanding Financial Strength Cord Blood Bank 2010 and 2011
TVB weekly The Most Popular Brand Award 2010 and 2011The Most Popular Cord Blood Bank
Metro Radio U Choice Lifestyle Brand 2010
Cordlife assures you of a cord blood unit of suitable match or SG$50,000 to defray medical costs if the cord blood unit loses its viability at the point of transplant*.
Optimal Condition Assurance Using CellOptima™ proprietary cell biomarker verification, your baby’s cord lining will be tested after 4 weeks of cryopreservation. During this process, sample segments of the frozen cord lining will be thawed and tested for cell viability and proliferation. This verification step is important as it helps ensure that your baby’s cord lining has been properly stored and can be used for future medical treatments. The objective of this process is to validate the following:
Quality Storage Assurance Your baby’s cord lining will be stored in its original, unexpanded raw form. This ensures minimal manipulation that helps to retain the stem cells’ original characteristics and gives your family greater access to:
*Terms & Conditions apply. Please refer to the Cordlife Service Agreement for full details.
Singapore is an ideal long-term storage place for your baby's cord blood unit because of its natural disaster-free location, political and socio-economic stability. Our facility at A'Posh Bizhub passed stringent audit conducted by Ministry of Health (MOH) Singapore as well as by AABB - so you can be assured of our strict adherence to national and international standards.
Your baby's cord blood will be stored in vacuum insulated cryogenic storage tanks housed inside fire retardant laboratory walls and are designed to remain at optimal temperature for cell storage over long periods. The tanks are monitored 24 hours a day, 365 days a year and our laboratory is also equipped with multiple backup systems to ensure continuous operation (undisrupted processing). It is Cordlife's lifelong commitment to safeguard your baby's cord blood unit under the best storage conditions in the most secure and safest place. With your one chance, make that one right choice with Cordlife.
Here at Cordlife, we understand the concerns of you as a parent and the assurance of continued storage of your baby's cord blood. In the very remote event that Cordlife Group Limited cease operations, Cordlife will assign your baby's cord blood to another provider of cord blood banking storage facilities that meets the necessary standards at the relevant time for licensing with the Ministry of Health (MOH) Singapore or of a comparable standard outside of Singapore. This is our assurance to you for the long term storage of your baby's cord blood.
Here at Cordlife, we understand the concerns of you as a parent and the assurance of continued storage of your baby's cord blood.
In the very remote event that Cordlife Group Limited cease operations, Cordlife will assign your baby's cord blood to another provider of cord blood banking storage facilities that meets the necessary standards at the relevant time for licensing with the Ministry of Health (MOH) Singapore or of a comparable standard outside of Singapore.
This is our assurance to you for the long term storage of your baby's cord blood.
Cordlife is Singapore's private cord blood bank with published successful cord blood transplant and application track records.
16 July 2016优1周- UWeekly - My child was born with cerebral palsy
17 June 2016Shin Min Daily News Cord blood saved baby with cerebral palsy
The table below features the cord blood releases performed by Cordlife Group Limited and its subsidiaries. As a Group, Cordlife has made 76 cord blood releases, all of which have been used successfully in transplants or cellular therapy. This is the ultimate validation of our cord blood processing and storage capability.
Providing private cord blood banking for the less privileged families.
Cordlife recognises that there are families who may benefit from cord blood banking but are financially challenged to do so. Obtaining a matching cord blood from the public source can cost as much as US$25,0001 and sometimes the search may be futile.
With Cordlife Cares, these families will have access to private cord blood banking, paid for by Cordlife. This means that eligible families will have genetically unique stem cells readily obtainable should a Haematopoietic Stem Cell (HSC) transplant be required.
Once accepted into the Cordlife Cares programme, Cordlife will provide the collection kit for the collection of cord blood. After the collection, the cord blood will be processed and stored until needed, without any cost to the family.
Should you wish to apply+ for this programme, or know of a family who may benefit from this programme, please call 6238 0808 or email cares@cordlife.com.
1 National Library Board Singapore website . Accessed February 19, 2009. * List of diseases treated can be found at www.cordlife.com/sg/treatablediseases + Cordlife reserves the right to assess eligibility and subsequent enrolment into the Cordlife Cares programme
We are inviting high calibre candidates to join our dynamic and passionate team in Singapore. With over 50,000 families (and growing) saving their babies' cord blood with Cordlife Group Limited, this is a fantastic opportunity to be part of a healthcare organisation that is fast-expanding! Be part of our dynamic team! Comprehensive training and development, remuneration package and staff benefits will be provided to the successful candidates. We welcome Singaporeans and Singapore PRs to apply. Kindly send your resume to:
Human Resources Department Cordlife Group Limited 1 Yishun Industrial Street 1 #06-01/09 A'Posh Bizhub Singapore 768160 Tel: (65) 6238 0808 Fax: (65) 6238 1108 Email: hr@cordlife.com
Corporate Identity Number: U85196WB2005PTC106719 Registered Office: P.L. Deuty Road, off Diamond Harbour Road Bishnupur,24 Parganas (S) West Bengal - 743503, India
Toll Free: 1800 345 6200 Tel: (91) 98 30166200 Fax: (91) 33 24809566
Unit 104 Building H UP-AyalaLand TechnoHub Commonwealth Ave. Bgy. UP Campus, Diliman Quezon City Philippines 1101 Mobiles: +63 998 848 6063 | +63 998 848 6064 Landlines : (02) 470 1735 | (02) 332 1888 Fax: (63) 2 3521304 Website: www.cordlife.com.ph Email: info@ph.cordlife.com
Corporate Office & Laboratory Jalan Bungur Besar Raya No. 23 Gunung Sahari Selatan, Kemayoran Central Jakarta, 10610 Indonesia Tel: (+62) -21 8086-4674 Fax: (+62) -21 8086-4675 Email: info@id.cordlife.com
Unit G15, G/F., Biotech Centre 2 No. 11 Science Park West Avenue Shatin New Territories, Hong Kong Tel: (852) 3980 2980 Fax: (852) 25118882 Email: info@hk.cordlife.com Cord Blood/Umblical Cord Collection Hotline: (852) 3980 2999
Suite 3603A, 36/F, Skyline Tower, 39 Wang Kwong Road, Kowloon Bay, Kowloon, Hong Kong Contact Information: Tel: (852) 3980 2888 Fax: (852) 25118882 Email: info@mo.cordlife.comCord Blood/Umblical Cord Collection Hotline: (852) 3980 2999
Fleet Company Ltd. Rua De Coelho Do Amaral No. 91R/C, Macau Tel: (853) 6881 0781 Fax: (853) 2835 2180 Email: info@mo.cordlife.com
B-7-15, Megan Avenue II, 12 Jalan Yap Kwan Seng, 50450 Kuala Lumpur, Malaysia 24hr Hotline: +603 2166 3636 Tel : +603 2163 8800 Fax : +603 2164 9808 Email: info@stemlife.com
Marketed by BIO Secure Co., Ltd.
631 Pyay Road, Kamaryut Township, YangonMyanmar 1104124 Hour Hotline 09 2652 88882
CMVN Joint Stock Company The Official Marketing Agent of Cordlife Group Limited in Vietnam Level 12, Minh Long Tower No. 17 Ba Huyen Thanh Quan, Ward 6 District 3, Ho Chi Min City 24 Hour Hotline +84 98 355 1644 Email: info@vn.cordlife.com
Our laboratory and processes are approved and certified by the following authorities. We ensure that we have the best practices in cord blood stem cells collection and banking. They are timely checked and we are audited according to their stringent criteria to achieve our accreditation.
